James A. McNulty - Chief Financial Officer at Inhibitor Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
INTI on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by James A. McNulty since 28 Sep 2025

Reported holdings for James A. McNulty in Inhibitor Therapeutics, Inc.

Form 4 holding Chief Financial Officer

Inhibitor Therapeutics, Inc.

Security class
Stock Option
Shares / value
100,000
Estimated value
Report date
16 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for James A. McNulty in Inhibitor Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .